SU-C-204-02: Behavioral and Pathologic Differences in Mice Exposed to Proton Minibeam Arrays Versus Proton Broad Beams
Creators
- 1. University of Maryland School of Medicine, Baltimore, MD (United States)
- 2. The University of Texas MD Anderson Cancer Center, Houston, TX (United States)
- 3. Stony Brook University Medical Center, Stony Brook, NY (United States)
Description
Purpose: Minibeam therapy using protons or light-ions offers a theoretical reduction of biologic damage to tissues upstream of a tumor compared to broad-beam therapy while providing equal tumor control. The purpose of this study was to investigate behavioral and pathologic differences in mice after exposure of healthy brain to proton minibeam arrays versus proton broad beams. Methods: Twenty-four C57BL/6J juvenile mice were divided into 5 study arms: sham irradiation (NoRT), broad-beam 10 Gy (BB10), minibeam 10Gy (MB10), broad-beam 30 Gy (BB30), and minibeam 30 Gy (MB30), approximate integral entrance doses. Circular beams of 100 MeV protons with 7-mm diameter were delivered laterally through the brain, either as broad beams or as planar minibeam arrays having 300-micron beam width and 1-mm spacing on center. Mice were followed for 8 months using standard behavioral tests. Pathologic studies were carried out at 8 months after irradiation. Results: Peak entrance doses were 10.0, 23.8, 30.0, and 71.3 Gy for mice in BB10, MB10, BB30, and MB30, respectively. Despite the high single-fraction doses, no animals showed signs of radiation sickness or neurophysical impairment over the 8-month study duration. The Morris water maze alternate-starting-position trial showed significant evidence of better spatial learning for mice in MB10 versus BB10 (p=0.026), but other behavioral tests showed no significant differences. Glial fibrillary acidic protein stains showed gliosis in arms BB10, BB30, and MB30 but not in NoRT or MB10. A secondary finding was categorically higher epilation in broad-beam arms compared with their minibeam dose counterparts. Conclusion: Our findings indicate trends that, despite the higher peak doses, proton minibeam therapy can reduce radiation side effects in shallow tissue and brain compared to proton broadbeam therapy. As the behavioral findings were mixed, confirmation studies are needed with larger numbers of animals. AAPM Research Seed Funding Grant
Additional details
Identifiers
- DOI
- 10.1118/1.4955526;
Publishing Information
- Journal Title
- Medical Physics
- Journal Volume
- 43
- Journal Issue
- 6
- Journal Page Range
- vp.
- ISSN
- 0094-2405
- CODEN
- MPHYA6
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 48071786
- Subject category
- S60: APPLIED LIFE SCIENCES; S61: RADIATION PROTECTION AND DOSIMETRY;
- Descriptors DEI
- ANIMAL TISSUES; BEAMS; BRAIN; EPILATION; IRRADIATION; LIGHT IONS; MICE; NEOPLASMS; PROTEINS; RADIATION DOSES; RADIOTHERAPY
- Descriptors DEC
- ANIMALS; BODY; CENTRAL NERVOUS SYSTEM; CHARGED PARTICLES; DISEASES; DOSES; IONS; MAMMALS; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; RADIOLOGY; RODENTS; THERAPY; VERTEBRATES
Optional Information
- Notes
- (c) 2016 American Association of Physicists in Medicine